The complicated legal dispute, which began in 2013, has been adjourned until Septber after ObjectiVision applied to change its claim, which saw the case stall last month.USyd publication Honi Soit reported the company was ordered to pay $21,525 as a result of the move, after USyd spent $31,250 fighting the application.ObjectiVision has amended its claim six times during the drawn out case and was also ordered to pay Visionsearch, USyd’s successor to the failed spin off, an undisclosed amount for the delay.The dispute, which has cost USyd millions of dollars in legal fees, has been ongoing since 2013 and is related to a licensing deal the university entered into in 1999 with ObjectiVision to commercialise its Accumap technology – a glaucoma testing device.However, the deal fell apart and USyd accused ObjectiVision of breaching multiple aspects of the licensing agreent, while ObjectiVision itself lodged a counterclaim against the university over the supposed theft and misuse of intellectual property (IP).The trial is set to resume on Septber 4.More reading: Save Sight Institute in costly legal battle
Multi-million dollar dispute over glaucoma tech continues
Creating a new normal in lens design with biometric data
As biometric intelligence continues to mature, normative data is progressively dismantling the ‘standard eye’ and reshaping how spectacle lenses are...
